IL6 and Duchenne muscular dystrophy: Moreover, circulating IL6 levels were significantly increased in DMD patients before initiation of treatment with glucocorticoids (GCs), compared to age matched controls and to DMD patients who were receiving GC treatment (Fig. 1D).